首页> 外文OA文献 >The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

【2h】

The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

机译：拟钙剂对终末期肾脏疾病中矿物质代谢和继发性甲状旁腺功能亢进的影响21世纪肾脏疾病合并症的管理：贫血和骨病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Block Geoffrey A.;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CaSR polymorphism Arg990Gly and response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism and in cell culture [J] . Hansjorg Rothe, Warren Shapiro, Wei Y Sun Personalized medicine . 2008,第2期

机译：CaSR基因多态性Arg990Gly和拟钙剂对继发性甲状旁腺功能亢进的终末期肾脏病患者和细胞培养的反应
2. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism [J] . Li Fang, Jining Wu, Jing Luo, BMC Nephrology . 2018,第1期

机译：终末期肾病继发性甲状旁腺功能亢进症患者不进行自体全甲状旁腺切除术后骨密度的变化
3. The Calcimimetic AMG 073 as a Potential Treatment for Secondary Hyperparathyroidism of End-Stage Renal Disease [J] . David A. Bushinsky, Donald J. Sherrard, L. Darryl Quarles, Journal of the American Society of Nephrology: JASN . 2003,第3期

机译：拟钙剂AMG 073可作为终末期肾脏疾病继发性甲状旁腺功能亢进症的潜在治疗方法
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Retrospective Analysis of Phase 3 Clinical Trial to Evaluate the Efficacy of Drug B in Anemia Secondary to Chronic Kidney Disease [D] . Pollard, Kellyn 2019

机译：第3期临床试验的回顾性分析，评价患有慢性肾病的贫血药物B的疗效
6. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism [O] . Li Fang, Jining Wu, Jing Luo, 2018

机译：终末期肾病合并继发性甲状旁腺功能亢进患者不进行自体全甲状旁腺切除术后骨密度的变化
7. Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease [O] . Llach Francisco, Fernández Elvira 2003

机译：肾性骨病概述：治疗失败的原因，临床观察，骨性病变的变化模式和未来的治疗方法21世纪肾脏疾病合并症的管理：贫血和骨病

The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease

著录项

引文网络

相似文献

相关主题

期刊订阅